DOCSLIB.ORG

Sero-Detection of Chlamydia Trachomatis Antibodies Among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sero-Detection of Chlamydia Trachomatis Antibodies Among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali Sero-detection of Chlamydia trachomatis Antibodies among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali B.Sc. in Medical Microbiology, Faculty of Medicine and Health Sciences, Shendi University (2011) A Dissertation Submitted to University of Gezira in Partial Fulfillment for the Requirements for the Award of the Degree of Master of Laboratory Science in Medical Microbiology Department of Medical Microbiology Faculty of Medical Laboratory Sciences May, 2018 i Sero-detection of Chlamydia trachomatis Antibodies among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali Supervision Committee: Name : Position Signature Dr: Nadir Musa Khalil Abuzeid Main supervisor …………. Dr: Adam Dawoud Abakar Co-supervisor …………. Date: …/…/2018 ii Sero-detection of Chlamydia trachomatis Antibodies among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali Examination Committee: Name Position Signature Dr: Nadir Musa Khalil Abuzeid Chairperson …..……. Dr: Wad-Elbehar Hamad Elneel External examiner ...…….... Dr: Sanaa Elfatih Husain Internal examiner ………… Date: …/…/2018 iii Declaration I authorized that my dissertation” Sero-detection of Chlamydia trachomatis Antibodies among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017)" submitted by me under the supervision of Dr: Nadir Musa Khalil Abuzeid and Prof. Adam Dawoud Abakar for the partial fulfillment for the award of Master degree in Medical Laboratory Sciences in Medical Microbiology. University of Gezira Faculty of Medical Laboratory Sciences Department of Medical Microbiology; Wad- Medani, Sudan and this is original and it was not submitted in part or in full, in any printed or electronic means, and is not being considered elsewhere for publication or submission awarding degree elsewhere. Name and Signature of Candidate Name: Mona Osman Ahmed Ali Signature: ……………………….… Place: Wad Madani Date: …/…/2018 iv Dedication To my parents; thanks for supporting me; Thanks for giving me a chance to prove and improve myself through all my path of life. To my brothers, sisters, husband, and my daughters. To my friends and all people support me. And of course, all my colleagues in master program Batch (3). If I forgot anyone, please don’t ever doubt my dedication and love for ALL. v Acknowledgements I am grateful to all of helped me in completing this dissertation and provided me with information and special thanks and appreciation to my supervisors: Dr. Nadir Musa Khalil Abuzeid, Assistant Professor and consultant of medical microbiology University of Omdurman Islamic university, Faculty of Medical Laboratory Sciences, Department of Medical microbiology who followed and supported me in all Stages of this dissertation. I deeply thanks to my Co-supervisor Prof. Adam Dawoud Abakar Salim for hir guidance and great help. I do appreciate effort of all Staff working in Medical Microbiology and Post graduate studies departments. Especial thank to all staff of Wad Madani Obstetrics and Gynecology Hospital For collaboration during data collection. My particular thanks to my best friends Alaa Faroge , Awad Elymani, Ahmed omer and all staff of the faculty of medical laboratory sciences in Gezira University. Finally I am grateful to all who helped me and dedicated his time and effort to help me and did not mentioned hear above. vi Sero-detection of Chlamydia trachomatis Antibodies among Pregnant Women, Wad Medani Maternity Teaching Hospital, Gezira State, Sudan (2017) Mona Osman Ahmed Ali Abstract Chlamydia trachomatis is an obligate intracellular microorganism; it has ability to form intra cytoplasmic inclusion bodies within infected cells. In pregnant women, colonization of Chlamydia trachomatis in the genital tract during early gestation has been associated with spontaneous preterm birth. This case control hospital based study aims to detect Chlamydia trachomatis antibodies (IgG and IgM) among spontaneous recurrent miscarriage and non- miscarriage women at Wad Medani Maternity Hospital, Gezira State. A total of 90 women with and without history of miscarriage were enrolled in this study. 45(50%) were women with recurrent miscarriage, while the other 45(50 %) were women without history of miscarriage. Five ml of blood specimens were collected from each woman and dispensed into Ethylene Diamine Tetra Acetic acid and plain containers. Serum was collected by centrifugation at 4000 r/min for 10 minutes. Sera were tested for the presence of Chlamydia trachomatis IgG antibodies and Chlamydia trachomatis IgM antibodies using indirect Enzyme Linked Immunosorbent Assay (ELISA) method, Demographic and clinical data were collected by structured questionnaire after a verbal consent. 3/45 (6.7 %) women of study subjects were positive for Chlamydia trachomatis IgG antibodies and 3/45(6.7%) were positive for Chlamydia trachomatis IgM antibodies, while 2(2.2) women of control group were positive for Chlamydia trachomatis IgM antibodies. The study concluded that seroprevalence rate of Chlamydia trachomatis IgG and IgM antibodies are higher among women with recurrent miscarriage than those without history of recurrent miscarriage. The study recommended the screening for pregnant women for Chlamydia trachomatis. vii الكشف المصلي عن اﻻجسام المضادة للمتدثرة الحثرية بين النساء الحوامل, مستشفي ود مدني التعليمي للنساء والتوليد , وﻻية الجزيرة, السودان )2017م( منى عثمان احمد علي ملخص الدراسة المتدثرة الحثرية هي من الكائنات الحية الدقيقة التي تعيش داخل الخﻻيا. لديها القدرة على تشكيل جسيمات داخل الخﻻيا المصابة. في النساء الحوامل ارتبط وجود المتدثرة الحثرية في الجهاز التناسلي أثناء الحمل بالوﻻدة المبكرة التلقائية. تهدف دراسة الحالة والشاهد المستندة إلى المستشفي إلى الكشف عن المتدثرة الحثرية بين النساء الﻻتي أصبن باﻻجهاض والنساء الﻻتي لم يصبن باﻻجهاض التلقائي المتكرر المتردات علي مستشفي ود مدني للنساء والتوليد, وﻻية الجزيرة. شملت الدراسة 90امرأة , 45 )50 ٪( كن لديهم اجهاض ، 45 آخرين )50 ٪( من النساء ليس لديهم تاريخ اﻹجهاض. تم جمع خمسة مل من عينات الدم من كل امرأة وتم توزيعها في انابيب اختبار تحتوى علي مضاد التجلط ايثايلين دايمين تترا اثيدك اسيد واخرى ﻻ تحتوي علي مانع تجلط . تم تحضير المصل بواسطة الطرد المركزي عند 4000 لفة / دقيقة لمدة 10 دقائق. تم اختبار اﻷمصال لوجود اﻷجسام المضادة )ج( و اﻷجسام المضادة )م( للمتدثرة الحثرية عن طريق استخدم طريقة الفحص المناعي المرتبط باﻹنزيم غير المباشر ، وتم جمع البيانات الديموغرافية والسريرية من خﻻل استبيان بعد الحصول على الموافقة شفهيا من المستهدفين. من بين 45 امراة لديها اجهاض كانت 3 نساء )6.7%( نتائجهم ايجابية لـﻻجسام المضادة )ج( للمتدثرة الحثرية. و ثﻻث نساء )6.7٪( كانت نتائجهم ايجابية لﻷجسام المضاد )م( للمتدثرة الحثرية. بينما اثنان )4.4%( من النساء الﻻتي لم يصبن باﻻجهاض كانت نتائجهم ايجابية لﻷجسام المضادة ( م( للمتدثرة الحثرية .وخلصت الدراسة الي أن معدل انتشار اﻻجسام المضادة )ج , م( للمتدثرة الحثرية وسط النساء الﻻتي تعرضن لﻻجهاض اعلي من معدل اﻻنتشار وسط النساء الﻻتي ليس لديهن تاريخ إجهاض. اوصت الدراسة بأهمية اجراء فحص روتيني للكشف عن المتدثرة الحثرية لكل النساء الحوامل . viii TABLE OF CONTENTS Number CONTENTS Page Supervision committee i Examination committee ii Declaration iii Dedication iv Acknowledgement v English abstract vi Arabic abstract vi Table of contents Vii List of tables viii List of abbreviations ix CHAPTER ONE 1.1 Introduction 1 1.2 Justification 2 1.3 Objectives 2 1.3.1 General objective 2 1.3.2 Specific Objectives 2 CHAPTER TWO LITERATURE REVIEW 2.1 Definition of miscarriage 4 2.2 Classification of miscarriage 4 2.3 Causes of miscarriage 4 2.4 Chlamydia Trachomatis 5 2.4.1 Taxonomy 5 2.4.2 General properties 5 2.4.3 Morphology 6 2.4.4 Genomics 7 2.4.5 Life cycle 7 2.4.6 Antigenicity 8 2.4.7 Pathogenesis and Immunity 8 2.4.8 Clinical Syndromes 9 2.4.8.1 Lymphogranuloma Venereum 10 2.4.8.2 Ocular genital Infections 10 2.4.8.3 Urogenital infections 10 2.4.8.4 Trachoma 11 ix 2.4.8.5 Neonatal pneumonia 11 2.4.8.6 Fitz-Hugh-Curtis 12 2.4.9 laboratory Diagnosis 12 2.4.9.1 Specimens 12 2.4.9.2 diagnostic methods 12 2.4.9.2.1 Direct cytological examination 12 2.4.9.2.2 Isolation in cell culture 13 2.4.9.2.3 Antigen Detection 13 2.4.9.2.4 Nucleic Acid Hybridization 13 2.4.9.2.5 Nucleic Acid Amplification Tests 14 2.4.9.2.6 Serodiagnosis 14 2.4.9.3 Antimicrobial susceptibility testing 15 2.4.10 Treatment 15 2.4.11 prevention and control 15 2.5 The Relationship between Chlamydia trachomatis Genital Infection 16 and Spontaneous Abortion 2.6 Previous studies 16 CHAPTER THREE (MATERIALS AND METHODS) 3.1 Study design 18 3.2 Study area 18 3.3 Study population 18 3.4 Sample Size 18 3/5 Study Criteria 18 3.5.1 Inclusion criteria 18 3.5.2 Exclusion criteria 19 3.6 Data collection 19 3.7 Data analysis 19 3.8 Ethical consideration 19 3.9 Laboratory method 19 3.9.1 Collection of blood specimens 19 3.9.2 Sample processing 19 3.9.3 CBCs processing 19 3.9.4 Enzyme linked immunosorbent assay (ELISA) processing 20 x 3.9.4.1 Principle of Enzyme linked immunosorbent assay (ELISA) for 20 detection of C. trachomatis IgG and IgM antibodies 3.9.4.2 Procedure 20 3.9.4.3 Quality control and calculation of results 21 CHAPTER FOUR 4.1 Results 22 4.2 Discussion 32 CHAPTER FIVE 5.1 Conclusion 35 5.2 Recommendations 35 References 36 Appendix 42 xi LIST OF TABLE Table Title Page 4.1 Socio-demogric and clinical characteristic of study population 23 4.2 Serodetection of anti C. trachomatis IgG and IgM according to Miscarriage 24 4.3 Serodetection of anti C. trachomatis IgG and IgM according to rate of miscarriage 24 4.4 Serodetection of anti C. trachomatis IgG and IgM according to trimester: 24 4.5 Serodetection of anti C. trachomatis IgG and IgM according to family history 25 4.6 Serodetection of anti C.
Load more

Recommended publications
  • Japan Society of Gynecologic Oncology Guidelines 2015 for the Treatment of Vulvar Cancer and Vaginal Cancer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Tsukuba Repository Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer 著者 Saito Toshiaki, Tabata Tsutomu, Ikushima Hitoshi, Yanai Hiroyuki, Tashiro Hironori, Niikura Hitoshi, Minaguchi Takeo, Muramatsu Toshinari, Baba Tsukasa, Yamagami Wataru, Ariyoshi Kazuya, Ushijima Kimio, Mikami Mikio, Nagase Satoru, Kaneuchi Masanori, Yaegashi Nobuo, Udagawa Yasuhiro, Katabuchi Hidetaka journal or International Journal of Clinical Oncology publication title volume 23 number 2 page range 201-234 year 2018-04 権利 (C) The Author(s) 2017. This article is an open access publication This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons. org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. URL http://hdl.handle.net/2241/00151712 doi: 10.1007/s10147-017-1193-z Creative Commons : 表示 http://creativecommons.org/licenses/by/3.0/deed.ja Int J Clin Oncol (2018) 23:201–234 https://doi.org/10.1007/s10147-017-1193-z SPECIAL ARTICLE Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer Toshiaki Saito1 · Tsutomu Tabata2 · Hitoshi Ikushima3 · Hiroyuki Yanai4 · Hironori Tashiro5 · Hitoshi Niikura6 · Takeo Minaguchi7 · Toshinari Muramatsu8 · Tsukasa Baba9 · Wataru Yamagami10 · Kazuya Ariyoshi1 · Kimio Ushijima11 · Mikio Mikami8 · Satoru Nagase12 · Masanori Kaneuchi13 · Nobuo Yaegashi6 · Yasuhiro Udagawa14 · Hidetaka Katabuchi5 Received: 29 August 2017 / Accepted: 5 September 2017 / Published online: 20 November 2017 © The Author(s) 2017.
    [Show full text]
  • Comparison of the Management of Vaginal Complaints in General Practice to a Protocol
    Comparison of the management of vaginal complaints in general practice to a protocol Introduction of the cervix, which are often caused by sexually transmitted pathogens, are less In the 'Standards' program of the Dutch easy to diagnose . Both a 'broad' approach College of General Practitioners, Stand­ and a strategy based on microbiological L. WIGERSMA ards (sets of guidelines) for quality medi­ diagnosis appear to besuitable for general cal care are developed.I 2 The Standards practice. The patient 's choice may often be Wigersma L. Comparison of the manage­ project was preceded by a research pro­ decisive . Variations in every phase of the ment of vaginal complaints in general prac­ gram for assessment of the feasibility and process ofcare can be accounted for. tice to a protocol. Huisarts Wet 1993; utility in daily practice of protocols for In this article, the diagnostic and thera­ 36(Suppl): 25·30. common conditions (the Protocols Pro­ peutic approach of vaginal disease in ject).' Decisive elements in the process of general practices in Amsterdam, the Abstract A protocol was developed for the problem solving (prior probability, prog­ Netherlands, is described and compared to approach of vaginal complaints, common con­ nosis, the efficacy of diagnostic tests and the corresponding elements of the proto­ ditions in general practice (GP). The manage­ ment of vaginal complaints in general practices treatments, and the influence of contextual col. The comparison specifically deals in Amsterdam, the Netherlands, was studied. factors such as the relationship between with the use and efficacy of office labora­ The diagnostic and therapeutic approach is de­ doctor and patient) are included in proto­ tory tests, microbiological tests, presump­ scribed and compared to the protocol.
    [Show full text]
  • Prevalence of Bacterial Vaginosis Among Patients with Vulvovaginitis in a Tertiary Hospital in Port Harcourt, Rivers State, Nigeria
    Asian Journal of Medicine and Health 7(4): 1-7, 2017; Article no.AJMAH.36736 ISSN: 2456-8414 Prevalence of Bacterial Vaginosis among Patients with Vulvovaginitis in a Tertiary Hospital in Port Harcourt, Rivers State, Nigeria 1 1* 1 1 1 K. T. Wariso , J. A. Igunma , I. L. Oboro , F. A. Olonipili and N. Robinson 1Department of Medical Microbiology and Parasitology, University of Port Harcourt Teaching Hospital, Nigeria. Authors’ contributions This work was carried out in collaboration between the authors. Author KTW designed the study and wrote the protocol. Author FAO wrote the first draft of the manuscript. Authors JAI and NR managed the literature search and performed statistical analysis. Author ILO managed the analysis of the study. All authors read and approved the final manuscript. Article Information DOI: 10.9734/AJMAH/2017/36736 Editor(s): (1) Jaffu Othniel Chilongola, Department of Biochemistry & Molecular Biology, Kilimanjaro Christian Medical University College, Tumaini University, Tanzania. Reviewers: (1) Olorunjuwon Omolaja Bello, College of Natural and Applied Sciences, Wesley University Ondo, Nigeria. (2) Ronald Bartzatt, University of Nebraska, USA. Complete Peer review History: http://www.sciencedomain.org/review-history/21561 Received 12th September 2017 Accepted 12th October 2017 Original Research Article Published 25th October 2017 ABSTRACT Background: Bacterial vaginosis (BV) is one of the three common causes of vulvovaginitis in women of child bearing age, usually resulting from alteration the normal vaginal microbiota and PH. Common clinical presentation includes abnormal vaginal discharge, pruritus, dysuria and dyspareunia. Aims: To determine the prevalence of bacterial vaginosis among symptomatic women of child bearing age that attended various outpatient clinics in the university of Port Harcourt teaching Hospital.
    [Show full text]
  • Update on Vaginal Infections
    PROGRESOS DE Obstetricia y Revista Oficial de la Sociedad Española Ginecología de Ginecología y Obstetricia Revista Oficial de la Sociedad Española de Ginecología y Obstetricia Prog Obstet Ginecol 2019;62(1):72-78 Revisión de Conjunto Update on vaginal infections: Aerobic vaginitis and other vaginal abnormalities Actualización en infecciones vaginales: vaginitis aeróbica y otras alteraciones vaginales Gloria Martín Saco, Juan M. García-Lechuz Moya Servicio de Microbiología. HGU Miguel Servet. Zaragoza Abstract It is estimated that abnormal vaginal discharge cannot be attributed to a clear infectious etiology in 15% to 50% of cases. Some women develop chronic vulvovaginal problems that are difficult to diagnose and treat, even by specialists. These disorders (aerobic vaginitis, desquamative inflammatory vaginitis, atrophic vaginitis, and cytolytic vaginosis) pose real challenges for clinical diagnosis and treatment. Researchers have established Key words: a diagnostic score based on phase-contrast microscopy. We review reported evidence on these entities and Vaginitis. present our diagnostic experience based on the correlation with Gram stain. We recommend treatment with Aerobic vaginitis. an antibiotic that has a very low minimum inhibitory concentration against lactobacilli and is effective against Parabasal cells. enterobacteria and Gram-positive cocci, which are responsible for these entities (aerobic vaginitis and desqua- Diagnosis. mative inflammatory vaginitis). Resumen Se estima que entre el 15 y el 50% de las mujeres que tienen trastornos del flujo vaginal, éstos no pueden atri- buirse a una etiología infecciosa clara. Algunas de ellas desarrollarán problemas vulvovaginales crónicos difíciles de diagnosticar y tratar, incluso por especialistas. Son trastornos que plantean desafíos reales en el diagnóstico Palabras clave: clínico y en su tratamiento como la vaginitis aeróbica, la vaginitis inflamatoria descamativa, la vaginitis atrófica y la vaginitis citolítica.
    [Show full text]
  • The Older Woman with Vulvar Itching and Burning Disclosures Old Adage
    Disclosures The Older Woman with Vulvar Mark Spitzer, MD Itching and Burning Merck: Advisory Board, Speakers Bureau Mark Spitzer, MD QiagenQiagen:: Speakers Bureau Medical Director SABK: Stock ownership Center for Colposcopy Elsevier: Book Editor Lake Success, NY Old Adage Does this story sound familiar? A 62 year old woman complaining of vulvovaginal itching and without a discharge self treatstreats with OTC miconazole.miconazole. If the only tool in your tool Two weeks later the itching has improved slightly but now chest is a hammer, pretty she is burning. She sees her doctor who records in the chart that she is soon everyyggthing begins to complaining of itching/burning and tells her that she has a look like a nail. yeast infection and gives her teraconazole cream. The cream is cooling while she is using it but the burning persists If the only diagnoses you are aware of She calls her doctor but speaks only to the receptionist. She that cause vulvar symptoms are Candida, tells the receptionist that her yeast infection is not better yet. The doctor (who is busy), never gets on the phone but Trichomonas, BV and atrophy those are instructs the receptionist to call in another prescription for teraconazole but also for thrthreeee doses of oral fluconazole the only diagnoses you will make. and to tell the patient that it is a tough infection. A month later the patient is still not feeling well. She is using cold compresses on her vulva to help her sleep at night. She makes an appointment. The doctor tests for BV.
    [Show full text]
  • Insights Into the Urogenial Microbiome of Females Suffering from Infectious
    From the Department of Infectious Diseases and Microbiology of the University of Lübeck Director: Prof. Dr. med. Jan Rupp The cervical microbiome in female infectious infertility: clinical trial and experimental mouse models Dissertation for Fulfillment of Requirements for the Doctoral Degree of the University of Lübeck from the Department of Natural Sciences Submitted by Simon Graspeuntner from Oberndorf b. Sbg. (Austria) Lübeck 2016 First referee: Prof. Dr. med. Jan Rupp Second referee: Prof. Dr. rer. nat. Ulrich Schaible Date of oral examination: 26.06.2017 Approved for printing: Lübeck, 06.07.2017 Table of content P a g e | I Table of content Abstract ........................................................................................................................... 1 Zusammenfassung .......................................................................................................... 3 1 Introduction .................................................................................................................... 5 1.1 Female infectious infertility ............................................................................................. 5 1.1.1 Female infertility is an important worldwide health issue .............................................. 5 1.1.2 Sexually transmitted diseases cause tubal factor infertility ............................................ 5 1.2 The microbiome of the female urogenital tract .............................................................. 7 1.2.1 Characterization of the vaginal microbiota
    [Show full text]
  • Vulvar Disease: Overview of Diagnosis and Management for College Aged Women
    Vulvar Disease: Overview of Diagnosis and Management for College Aged Women Lynette J. Margesson MD FRCPC ACHA 2013 Annual Meeting, May 30, 2013 No Conflicts of interest Lynette Margesson MD Little evidence based treatment Most information is from small open trials and clinical experience. Most treatment discussed is “off-label” Why Do Vulvar Disease ? Not taught Not a priority Takes Time Still an area if taboo VULVAR CARE IS COMMONLY UNAVAILABLE For women this is devastating Results of Poor Vulvar Care Women : - suffer with undiagnosed symptoms - waste millions of dollars on anti-yeasts - hide and scratch - endure vulvar pain and dyspareunia - are desperate for help VULVA ! What is that? Down there? Vulvar Education Lets eliminate the “Down there” generation Use diagrams and handouts See www.issvd.org - patient education Recognize Normal Anatomy Normal vulvar anatomy Age Race Hormones determine structure - Size & shape - Pigmentation -Hair growth History A good,detailed,accurate history All previous treatment Response to treatment All medications, prescribed and over-the-counter TAKE TIME TO LISTEN Genital History in Women Limited by: embarrassment lack of knowledge social taboos Examination Tips Proper visualization - light + magnification Proper lighting – bright, but no glare Erythema can be normal Examine rest of skin, e.g. mouth, scalp and nails Many vulvar diseases scar, not just lichen sclerosus Special Anatomic Variations Sebaceous hyperplasia ectopic sebaceous glands Vulvar papillomatosis Pre-anesthesia – BIOPSY use a topical
    [Show full text]
  • Erosive Lichen Planus Affecting the Vulva
    EROSIVE LICHEN PLANUS AFFECTING THE VULVA: Defining the disease, developing outcome measures and designing a randomised controlled trial Rosalind C Simpson BMedSci, BMBS, MRCP(UK) Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy December 2014 Abstract Erosive lichen planus (ELP) is a chronic, inflammatory, scarring skin condition that occurs predominantly on the mucosal surfaces of the mouth and genital region. It is believed to be an autoimmune condition although the exact pathogenesis remains unclear. This thesis focuses on ELP affecting the vulvovaginal region (ELPV). This is a rare condition with unknown incidence and prevalence. It causes painful raw areas at the vaginal entrance and subsequent scarring leads to anatomical changes with narrowing of the vaginal canal. Symptoms lead to difficulty in normal daily activities such as walking/sitting, washing, going to the toilet and can prevent normal sexual function. There is risk of cancerous change in affected skin of 1-3%. A Cochrane Systematic Review of interventions for mucosal erosive lichen planus, published in 2012, found no randomised controlled trials (RCT) on which to base treatment for ELPV. Evidence for treatments has historically been based upon retrospective case- series and case reports. Retrospective case series suggest that super-potent topical corticosteroids an effective first-line therapy, although one third of patients fail to respond adequately and require I Abstract escalation of therapy. There is no agreement for which second-line agents should be used and this is where the greatest clinical need for therapeutic guidance exists. The objective of this PhD was to begin to standardise practice for the management of people with ELPV and then develop a pragmatic protocol for those individuals who had failed to adequately respond to first line therapy with super-potent topical corticosteroids.
    [Show full text]
  • Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors
    Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors Caroline F. Pukall, PhD,1,a Andrew T. Goldstein, MD,2,a Sophie Bergeron, PhD,3 David Foster, MD,4 Amy Stein, DPT,5 Susan Kellogg-Spadt, PhD,6 and Gloria Bachmann, MD7 ABSTRACT Introduction: Vulvodynia constitutes a highly prevalent form of chronic genital pain in women, and current information regarding its definition, prevalence, impact, and pathophysiologic factors involved is needed. Aim: To update the scientific evidence published in 2010 from the Third International Consultation of Sexual Medicine pertaining to the definition, prevalence, impact, and pathophysiologic factors of women’s sexual pain. Methods: An expert committee, as part of the Fourth International Consultation of Sexual Medicine, comprised of researchers and clinicians from biological and social science disciplines, reviewed the scientific evidence on the definition, prevalence, impact, and pathophysiologic factors related to chronic genital pain. Main Outcome Measures: A review of the definition, prevalence, impact, and pathophysiological factors involved in vulvodynia. Results: Vulvodynia is a prevalent and highly impactful genital pain condition. Numerous factors have been implicated in its development and maintenance. Conclusion: What is becoming increasingly apparent is that it likely represents the end point of different factors that can differ from patient to patient. Longitudinal research is needed to shed light on risk factors involved in the expression of vulvodynia, as well as in potential subgroups of affected patients, in order to develop an empirically supported treatment algorithm. J Sex Med 2016;13:291e304. Copyright Ó 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved. Key Words: Vulvodynia; Sexual Pain; Vestibulodynia; Prevalence; Definition; Pathophysiologic Factors; Dyspareunia DEFINITION deep pelvic areas.
    [Show full text]
  • GCPR on Endometriosis
    GOOD CLINICAL PRACTICE RECOMMENDATIONS ON ENDOMETRIOSIS Theme: Enigmatic Disease - Educate Empower and Eradicate Editorial grant from Jagsonpal FOGSI GOOD CLINICAL PRACTICE RECOMMENDATIONS ON ENDOMETRIOSIS Under the agesis of FOGSI Endometriosis Committee 2014 – 2016 Convener: Dr.AlkaKriplani, President FOGSI 2016 – New Delhi Vice Presidents in-charge: Dr.Sadhana Gupta, Gorakhpur Dr.BharatiDhorepatil, Pune Assistant Secretary FOGSI 2016 Dr. Garima Kachhawa, Co – ordinator: Dr. T. Ramani Devi, Chairperson Endometriosis Committee 2014 – 2016, Trichy Editorial Assistant: Dr.SripriyaPragasam, Trichy Experts: Dr.Basab Mukherjee, Kolkata Dr.Bhaskar Pal, Kolkata Dr.SunitaTandulwadhkar, Pune Dr.NeerjaBhatla, New Delhi Dr.Aparna Sharma, New Delhi Dr.RekhaKurian, Chennai Dr.KananYelikar, Aurangabad Dr.KanthiBansal, Ahmedabad Dr.ManjuVerma, Allahabad Dr. Vinita Das, Lucknow Dr. Mala Arora, Faridabad Dr. Sonia Malik, New Delhi INDEX 1. Diagnosis of Endometriosis 2. Adolescent Endometriosis 3. Endometriosis and Infertility 4. Medical management of Endometriosis 5. Surgical management of Endometriosis 6. Pain management of Endometriosis 7. Recurrent Endometriosis 8. Endometriosis and Malignancy 9. Asymptomatic Endometriosis 10. Adenomyosis 11. Scar Endometriosis Introduction Endometriosis is an enigmatic disease. As per definition it is the presence of endometrial glands and stroma, outside the uterine cavity which induces chronic inflammatory reaction. General incidence is around 10 % of the women of reproductive age group. Among the infertile women
    [Show full text]
  • Office Gynaecology
    O Magazine&G Vol 16 No 3 Spring 2014 Office gynaecology The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Contents Office gynaecology 13 Editorial OMagazine& G Brett Daniels O&G Magazine Advisory Group 14 Contraception: a new focus Dr Gillian Gibson Fellows Rep, New Zealand Suzanne Pearson and Sumudu Cooray A/Prof Stephen Robson Fellows Rep, ACT Dr John Schibeci Diplomates Rep, NSW 17 Hysteroscopic sterilisation Dr Brett Daniels Young Fellows Rep, TAS Dr Alexa Bendall Trainees Rep, QLD Astrid Budden Magazine Editors O&G 21 Mirena: modern-day miracle Penelope Griffiths Julia Serafin Edwina Morgan Lisa Westhaven 24 Colposcopy 2014 Designer and Production Editor Lisa Westhaven Louise Farrell Editorial Communications 26 NCSP renewal: 2016 O&G Magazine Advisory Group, RANZCOG Ian Hammond 254–260 Albert Street EAST MELBOURNE, VIC 3002 Australia 27 Investigating fertility (t) +61 3 9417 1699 Tamara Hunter (f) +61 3 9419 0672 (e) [email protected] 30 Polycystic ovarian syndrome Advertising Sales Megan Ogilvie Bill Minnis Director Minnis Journals (t) +61 3 9836 2808 33 Pelvic inflammatory disease (f) +61 3 9830 4500 Shannon Woodward and Sarah Martin (e) [email protected] Printer 36 Vulval pain: a registrar’s view Highway Press Nicola Quirk (t) +61 3 9887 1388 (f) +61 3 9800 2270 38 Medication management of chronic pelvic pain Susan Evans O&G Magazine authorised by Mr James McAdam © 2014 The Royal 40 Outpatient hysteroscopy Australian and New Zealand College of Obstetricians and Gynaecologists Namiko Kobayashi and Boon Lim (RANZCOG). All rights reserved. No part of this publication may be reproduced or 44 Hysteroscopy: tools, tips, tricks copied in any form or by any means without Khaldoun Aweidah the written permission of the publisher.
    [Show full text]
  • Vulval Disease - Flash Card Set
    VULVAL DISEASE - FLASH CARD SET British Society for the study of Vulval Disease www.bssvd.org Overview This set of flash cards was developed to help women’s healthcare providers (doctors, nurses) improve their skills in the assessment and management of vulval disease. These cards can be used as a training tool to improve those skills with regards lesion description, making a diagnosis and treatment options. The cards are by no means comprehensive but are designed to stimulate discussion and increase self-knowledge. About This Card Set This card set contains flash cards, which are numbered to allow the trainee or trainer to track which cards were viewed during an exercise. The front of each card displays a colour version of the vulval image and questions. The back of the card has the questions with short note form answers. There are also other relevant points of interest on the disease with additional information on prognosis and complications if relevant. Algorithm for the management of vulval itch and pain Lesion(s) to see (eg ulcer, lump, Vulval itch indurated Vulval ‘pain’ area) consider Discharge or weepy skin? biopsy Yes No Rash/ redness? Ye s No Swab and treat Is the architecture normal? Esp candida Provoked pain on touch? Yes No Yes No Lichen sclerosus Fissure? Provoked Eczema/ psoriasis Unprovoked Lichen planus Vaginismus? vulvodynia Emollients and topical vulvodynia Emollients and (Vestibulodynia) steroids Psychosexual topical steroids referral? Other regional pain syndromes? GP and Pain clinic? Vaginal oestrogen Refer if not confidence, non-responder, complicated disease FLASH CARD No. 1 What is the likely diagnosis? What signs in the picture suggest this diagnosis? How is the condition diagnosed? What is the most likely treatment? Produced by the Education and Training Group, British Society for the Study of Vulval Disease www.bssvd.org Images copyrighted - reprinted c permission from the owner FLASH CARD No.
    [Show full text]